Clinical trial
Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal…
NCT00247988 · University of Saskatchewan, Other · Terminated
Key facts
| NCT number | NCT00247988 |
|---|---|
| Title | Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers |
| Official title | Phase II Study of Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers |
| Lead sponsor | University of Saskatchewan, Other |
| Collaborators | Sanofi Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Platinum Sensitive Relapsed Ovarian Cancer |
| Intervention type | Drug |
| Interventions | Weekly Taxotere with weekly carboplatin |
| Enrollment | 38 |
| Start date | Oct 1, 2003 |
| Completion | Apr 1, 2007 |
| First posted | Nov 2, 2005 |
| Last update posted | Apr 24, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: